Article
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Cancer prevention research (Philadelphia, Pa.) - 1 Jul 2011
Thorne Heather, Willems Amber J, Niedermayr Eveline, Hoh Ivan M Y, Li Jason, Clouston David, Mitchell Gillian, Fox Stephen, Hopper John L, Bolton Damien
Abstract excerpt
The role of a germ-line BRCA2 mutation in the development of prostate cancer is established, but the clinical presentation linked to outcome for this group of men has not been well described. A total of 148 men from 1,423 families were ascertained from the kConFab consortium. Each participant met the following criteria: (i) a verified case of prostate cancer; (ii) confirmed as either a carrier or noncarrier of a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
